Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LADR
|
Brian Harris
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 12,700 Reduced 1.65% |
$127,000
$10.0 p/Share
|
Dec 28
2020 |
|
LADR
|
Robert Perelman
Head of Asset Management |
SELL
Open market or private sale
|
Direct | 1,572 Reduced 0.53% |
$15,720
$10.0 p/Share
|
Dec 28
2020 |
|
LADR
|
Pamela Mc Cormack
President |
SELL
Open market or private sale
|
Direct | 39,188 Reduced 5.4% |
$391,880
$10.0 p/Share
|
Dec 28
2020 |
|
MNTV
|
Thomas E Hale
President |
SELL
Open market or private sale
|
Direct | 6,890 Reduced 1.86% |
$179,140
$26.0 p/Share
|
Dec 28
2020 |
|
MYOV
|
Frank Karbe
Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct | 11,800 Reduced 6.73% |
$354,000
$30.0 p/Share
|
Dec 28
2020 |
|
ADPT
|
Chad M Robins
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 16,250 Reduced 0.91% |
$1,008,312
$62.05 p/Share
|
Dec 28
2020 |
|
ADPT
|
Julie Rubinstein
President and COO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$938,250
$62.55 p/Share
|
Dec 28
2020 |
|
RGNX
|
Kenneth T. Mills |
SELL
Open market or private sale
|
Direct | 6,500 Reduced 2.63% |
$317,330
$48.82 p/Share
|
Dec 28
2020 |
|
KREF
|
Tactical Value Spn Kref Holdings L.P. |
SELL
Open market or private sale
|
Indirect | 43,791 Reduced 3.38% |
$811,885
$18.54 p/Share
|
Dec 28
2020 |
|
FGEN
|
Kalevi Kurkijarvi
Director |
SELL
Open market or private sale
|
Direct | 6,001 Reduced 15.35% |
$244,601
$40.76 p/Share
|
Dec 28
2020 |
|
SSP
|
William Appleton |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 3.77% |
$75,000
$15.0 p/Share
|
Dec 28
2020 |
|
RCKT
|
Kinnari Patel |
SELL
Open market or private sale
|
Direct | 16,761 Reduced 15.0% |
$952,695
$56.84 p/Share
|
Dec 28
2020 |
|
MORF
|
Omega Fund V, L.P.
Director |
SELL
Open market or private sale
|
Direct | 9,466 Reduced 0.32% |
$310,485
$32.8 p/Share
|
Dec 28
2020 |
|
MORF
|
Robert E Farrell Jr
SVP Finance and CAO |
SELL
Open market or private sale
|
Direct | 12,636 Reduced 26.36% |
$413,197
$32.7 p/Share
|
Dec 28
2020 |
|
FOR
|
G.F. (Rick) Ringler Iii
Director |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 40.0% |
$42,040
$21.02 p/Share
|
Dec 28
2020 |
|
YMAB
|
Thomas Gad
CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 100.0% |
$363,860
$51.98 p/Share
|
Dec 28
2020 |
|
ARR
|
John P Hollihan Iii
Director |
SELL
Open market or private sale
|
Direct | 9,721 Reduced 19.56% |
$104,987
$10.8 p/Share
|
Dec 28
2020 |
|
RPTX
|
Michael Zinda
EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct | 15,048 Reduced 17.65% |
$517,952
$34.42 p/Share
|
Dec 28
2020 |
|
CSTL
|
Daniel Bradbury
Director |
SELL
Open market or private sale
|
Indirect | 15,000 Reduced 0.66% |
$1,091,250
$72.75 p/Share
|
Dec 28
2020 |
|
PETQ
|
John Newland
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 9.44% |
$324,000
$36.0 p/Share
|
Dec 28
2020 |
|
BAND
|
David A. Morken
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 45,751 Reduced 98.22% |
$7,617,999
$166.51 p/Share
|
Dec 28
2020 |
|
ABML
|
John Hunter William
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.18% |
$30,600
$1.53 p/Share
|
Dec 28
2020 |
|
IEA
|
Gil Melman
General Counsel |
SELL
Open market or private sale
|
Direct | 9,154 Reduced 7.4% |
$169,441
$18.51 p/Share
|
Dec 28
2020 |
|
IEA
|
Derek Glanvill
Director |
SELL
Open market or private sale
|
Direct | 25,261 Reduced 26.66% |
$468,844
$18.56 p/Share
|
Dec 28
2020 |
|
BTAI
|
Vincent O'Neill |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 100.0% |
$1,304,750
$52.19 p/Share
|
Dec 28
2020 |
|
ALPN
|
Peter A. Thompson
Director |
SELL
Open market or private sale
|
Indirect | 600,000 Reduced 16.34% |
$8,550,000
$14.25 p/Share
|
Dec 28
2020 |
|
SMLR
|
Douglas Murphy Chutorian
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 1,250 Reduced 0.54% |
$114,712
$91.77 p/Share
|
Dec 28
2020 |
|
AKTS
|
Suzanne B Rudy |
SELL
Open market or private sale
|
Direct | 927 Reduced 0.96% |
$11,801
$12.73 p/Share
|
Dec 28
2020 |
|
IMMR
|
William C Martin
Chief Strategy Officer |
SELL
Open market or private sale
|
Indirect | 1,093,710 Reduced 28.94% |
$10,587,113
$9.68 p/Share
|
Dec 28
2020 |
|
KVHI
|
Robert J Balog
COO |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.1% |
$1,154
$11.54 p/Share
|
Dec 28
2020 |
|
MLSS
|
Joseph D'Agostino
CFO & COO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 1.81% |
$39,400
$1.97 p/Share
|
Dec 28
2020 |
|
EQ
|
Stephen Connelly
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 2.46% |
$113,000
$4.52 p/Share
|
Dec 28
2020 |
|
TYME
|
Michael Demurjian
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.08% |
$22,400
$1.12 p/Share
|
Dec 28
2020 |
|
GLYC
|
Rachel K. King |
SELL
Open market or private sale
|
Direct | 84,176 Reduced 19.12% |
$329,128
$3.91 p/Share
|
Dec 28
2020 |
|
CYCN
|
Mark G Currie
President and CSO |
SELL
Open market or private sale
|
Direct | 20,107 Reduced 7.4% |
$60,522
$3.01 p/Share
|
Dec 28
2020 |
|
APLT
|
Riccardo Perfetti
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 465 Reduced 100.0% |
$10,142
$21.81 p/Share
|
Dec 28
2020 |
|
AWX
|
Bryan Saksa
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 24,000 Reduced 100.0% |
$108,000
$4.5 p/Share
|
Dec 28
2020 |
|
LOVE
|
Albert Jack Krause
Director |
SELL
Open market or private sale
|
Direct | 6,816 Reduced 5.44% |
$283,886
$41.65 p/Share
|
Dec 28
2020 |
|
PLAN
|
Sandesh Kaveripatnam
Director |
SELL
Open market or private sale
|
Direct | 2,184 Reduced 2.79% |
$164,477
$75.31 p/Share
|
Dec 28
2020 |
|
CSLT
|
Seth B. Cohen
Director |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 7.45% |
$45,000
$1.5 p/Share
|
Dec 28
2020 |
|
ATAO
|
Erop Capital LLC |
SELL
Open market or private sale
|
Direct | 80,000 Reduced 0.16% |
$23,200
$0.29 p/Share
|
Dec 28
2020 |
|
HGEN
|
Nomis Bay Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.01% |
$11,100
$22.2 p/Share
|
Dec 28
2020 |
|
GSHD
|
Mark & Robyn Jones Descendants Trust 2014
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 29,518 Reduced 100.0% |
$3,647,834
$123.58 p/Share
|
Dec 28
2020 |
|
GSHD
|
Robyn Mary Elizabeth Jones
Director |
SELL
Open market or private sale
|
Indirect | 29,518 Reduced 38.77% |
$3,647,834
$123.58 p/Share
|
Dec 28
2020 |
|
GSHD
|
Mark Evan Jones
Executive Chairman |
SELL
Open market or private sale
|
Indirect | 29,518 Reduced 38.77% |
$3,647,834
$123.58 p/Share
|
Dec 28
2020 |
|
CURO
|
Donald Gayhardt
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 1.9% |
$213,450
$14.23 p/Share
|
Dec 28
2020 |
|
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
BUY
Open market or private sale
|
Indirect | 7,000 Added 0.03% |
$1,610
$0.23 p/Share
|
Dec 28
2020 |
|
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 410 Reduced 0.0% |
$98
$0.24 p/Share
|
Dec 28
2020 |
|
CIDM
|
Peixin Xu
Director |
SELL
Open market or private sale
|
Indirect | 1,831,918 Reduced 4.48% |
$1,154,108
$0.63 p/Share
|
Dec 28
2020 |
|
CCB
|
Eric M Sprink
CEO |
SELL
Open market or private sale
|
Indirect | 4,691 Reduced 100.0% |
$101,373
$21.61 p/Share
|
Dec 28
2020 |